IL-BAI
19.8.2019 19:52:08 CEST | Business Wire | Press release
BAI announced the finalists for the 2019 BAI Global Innovation Awards, the industry’s most prestigious awards program that celebrates transformative solutions in the financial services industry worldwide.
Now in its ninth year, the BAI Global Innovation Awards recognizes leading financial services organizations on a global scale. Through hundreds of applications, the Innovation Circle , a panel of global financial services innovation leaders who thoroughly review each application, determined the top submissions.
The judges weigh each innovation on originality and impact on consumers and the industry. This year’s finalists showcase what leading financial services innovators in all regions of the world are doing to deliver new value to customers and employees, as well as improve efficiencies and profitability for their organizations.
The 2019 BAI Global Innovation Awards finalists are:
Best Application of Advanced Technology in a Product or Service
- Emirates NBD, Dubai, United Arab Emirates: Emirates NBD Blockchain Center of Excellence for Payments
- ISBANK, Istanbul, Turkey: AI Personal Assistant “Maxi”
- Shenzhen OneConnect Smart Technology Co., Ltd, Shanghai, China: FiMAX Trade Finance Blockchain Network
- Yapı Kredi, Istanbul, Turkey: Financial Document Corrective Analysis
Business Model Innovation
- CaixaBank S.A., Barcelona, Spain: Travel Marketplace
- DenizBank, Istanbul, Turkey: DenizBank Banking as a Platform Initiative
- KASIKORNBANK PCL, Bangkok, Thailand: K PLUS Loyalty Card Platform
- Royal Bank of Canada (RBC), Toronto, Canada: RBC Ventures
Human Capital Innovation
- Alior Bank S.A., Warsaw, Poland: Smartphonisation
- DenizBank, Istanbul, Turkey: Crowdfunding Platform, Fonosentez
- HDFC Bank, Mumbai, India: Recruitment Hackathon
- ISBANK, Istanbul, Turkey: Isbank Agile Atelier
- Ping An Insurance, Shenzhen, China: AI Interview System
Innovation in Customer Experience
- CaixaBank S.A., Barcelona, Spain: ATM Facial Recognition
- Commonwealth Bank of Australia, Sydney, Australia: Customer Experience Transformation via AI
- Emirates NBD, Dubai, United Arab Emirates: Customer Experience Month
- FNB Insurance, Johannesburg, South Africa: Claims Excellence
- The Bank of East Asia, Limited, Hong Kong: i-Planner
Innovation in Marketing
- CaixaBank S.A., Barcelona, Spain: imaginBank Agile Digital Marketing Room
- Elevate Credit, Fort Worth, Texas, U.S.: Elevate Credit Campaign 2019
- Fifth Third Bancorp, Cincinnati, Ohio, U.S.: Momentum Campaign
- ISBANK, Istanbul, Turkey: Maximum Gaming Esports Platform
- Pelican State Credit Union, Baton Rouge, Louisiana, U.S.: Pelican State of Mind
Innovation in Societal and Community Impact
- Absa Group Limited, Johannesburg, South Africa: Kongola
- BMO Harris Bank and Springfour, Chicago, Illinois, U.S.: BMO Harris - SpringFour Partnership
- JUMO.WORLD, Cape Town, South Africa: JUMO.WORLD
- Union Bank of the Philippines, Pasig, Philippines: Project i2i
Innovative Accelerator or Incubator
- Alior Bank S.A., Warsaw, Poland: RBL_START
- Citi Ventures, D10X, San Francisco, California, U.S.: D10X
- ISBANK, Istanbul, Turkey: Workup Entrepreneurship Program
- Royal Bank of Canada (RBC), Toronto, Canada: RBC Reach
- Woodforest National Bank, The Woodlands, Texas, U.S.: Woodforest Foundry
Innovative Touchpoints and Connected Experiences
- Aviva, Warsaw, Poland: Automated Claims Resolution Platform
- mBank S.A., Warsaw, Poland: Omni-channeling Asynchronous Chat
- Royal Bank of Canada (RBC), Toronto, Canada: DRIVE by RBC Ventures
Internal Process Innovation
- Alior Bank S.A., Warsaw, Poland: Smart Operations
- CommunityAmerica Financial Solutions, LLC, Lenexa, Kansas, U.S.: Dash360
- D10X, Citi, London, United Kingdom: Proxymity
- HDFC Bank, Mumbai, India: AI as a Service
- PKO Bank Polski, Warsaw, Poland: x-Platform
RegTech Innovation
- Hummingbird Regtech Inc, Walnut, California, U.S.: Regtech Solution
- Moody’s Analytics, San Francisco, California, U.S.: RiskFoundation™ Suite Hosted and Banking Cloud Solution
- Shenzhen OneConnect Smart Technology Co., Ltd, Shanghai, China: GAMMA Voiceprint Anti-fraud
- TSYS, Columbus, Georgia, U.S.: Foresight Score
- Yapı Kredi, Istanbul, Turkey: Digital Onboarding via Video Assistants
Congratulations to all the finalists of the BAI Global Innovation Awards. To learn more please visit BAIGlobalInnovations.com .
About BAI
As a nonprofit, independent organization, BAI delivers the financial services industry’s most actionable insights, enabling leaders to make smart business decisions every day. BAI is passionate about the trusted information and powerful tools that provide leaders with the clarity and confidence needed to drive positive change and move the financial services industry forward. For more information, visit www.bai.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190819005533/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom